Live
- Opposition Slams ‘One Nation, One Election’ Bill as Anti-Democratic; BJP Allies Support the Move
- Celebrate Karthigai Maha Deepam Virtually with Sri Mandir’s LIVE Darshan Experience
- BJP Extends Support to Samagra Shiksha Abhiyan Employees' Strike, Demands Immediate Regularization and Welfare Benefits
- Dr. M. Priyanka Stresses Quality Education, Nutritious Meals, and Cleanliness in Schools
- Mandal Level CM Cup Sports Concludes in Ija with Promising Talent and Enthusiastic Participation
- Harish Rao Slams Revanth Reddy: "More Talk, Less Action"
- Revolutionising Oil and Gas: Gaurav Kumar Sinha’s AI-Driven Innovations Transforming Efficiency and Profitability
- AiDASH Names Vishal Jain Head of AI to Advance First Integrated Platform for Grid Inspection and Monitoring
- Congress Central Election Committee has finalised the names of around 20 candidates for the upcoming Delhi Assembly elections
- District Collector Adarsh ​​Surabhi has ordered to expedite the land acquisition process related to irrigation projects in the district
US launches largest trial of precision medicine in cancer
Highlights
The United States launched the largest clinical trial of its kind Monday aimed at studying targeted therapies for cancer based on the genetic traits of tumors, a field known as precision medicine.
The United States launched the largest clinical trial of its kind Monday aimed at studying targeted therapies for cancer based on the genetic traits of tumors, a field known as precision medicine.
The US National Cancer Institute plans to enroll about 1,000 patients beginning in July, experts said at the American Society of Clinical Oncology meeting in Chicago.
"This is the largest and most rigorous precision oncology trial in history," said James Doroshow, deputy director of the National Cancer Institute, during a press conference at ASCO.
Rather than treating cancer based on its location -- whether breast, colon, lung or otherwise -- the approach consists of identifying the molecular anomalies of different cancers in order to determine the best treatments for each individual.
For example, a patient with lung cancer might be best treated with a medicine typically used for another kind of cancer, such as breast cancer, if the tumors share a similar mutation.
The project was described in broad strokes by President Barack Obama in his State of the Union address in January.
The promise of precision medicine is that it may someday lead to more effective treatments and shorter clinical trials for the some 200 different types of tumors known today.
The trial`s name is NCI-MATCH: Molecular Analysis for Therapy Choice.
Researchers will refer to an arsenal of more than 20 different study drugs or drug combinations, "each targeting a specific gene mutation, in order to match each patient in the trial with a therapy that targets a molecular abnormality in their tumor," said a statement from the NCI.
Those eligible to enroll include adults 18 years or older with solid tumors or lymphomas that have advanced despite at least one form of standard therapy.
Subjects could also include people with tumors who have no standard treatment.
At least a quarter of those enrolled must be people with rare forms of cancer.
Next Story
ADVERTISEMENT
